# A Study of Laquinimod Eye-drops in Healthy Participants

> **NCT05187403** · PHASE1 · COMPLETED · sponsor: **Active Biotech AB** · enrollment: 54 (actual)

## Conditions studied

- Eye Diseases

## Interventions

- **DRUG:** Laquinimod
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05187403
- **Lead sponsor:** Active Biotech AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-09
- **Primary completion:** 2023-01-19
- **Final completion:** 2023-01-19
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2023-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05187403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05187403, "A Study of Laquinimod Eye-drops in Healthy Participants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05187403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*